Table 2.
Demographic characteristics of hemodialysis patients with and without elevated anxiety symptoms during the early COVID-19 pandemic and at 1-year follow-up (n = 100).
| Early COVID-19 pandemic | One-year follow-up | |||||
|---|---|---|---|---|---|---|
| Characteristics | SAS score <50 (n = 60) | SAS score ≥50 (n = 40) | p-value | SAS score <50 (n = 72) | SAS score ≥50 (n = 28) | p-value |
| Female, n (%) | 26 (43.3%) | 19 (47.5%) | 0.682 | 34 (47.2%) | 11 (39.3%) | 0.474 |
| Age (years), n (%) | 0.347 | 0.289 | ||||
| <45 | 16 (26.7%) | 6 (15%) | 13 (18.1%) | 8 (28.6%) | ||
| 45–59 | 23 (38.3%) | 16 (40%) | 27 (37.5%) | 12 (42.9%) | ||
| ≥60 | 21 (35%) | 18 (45%) | 32 (44.4%) | 8 (28.6%) | ||
| Education, n (%) | 0.040 | 0.428 | ||||
| Primary or less | 14 (23.3%) | 18 (45%) | 21 (29.2%) | 11 (39.3%) | ||
| Junior or senior | 29 (48.3%) | 17 (42.5%) | 36 (50.0%) | 10 (35.7%) | ||
| University degree or above | 17 (28.3%) | 5 (12.5%) | 15 (20.8%) | 7 (25.0%) | ||
| Occupation, n (%) | 0.638 | 0.505 | ||||
| Employment | 17 (28.3%) | 8 (20%) | 17 (23.6%) | 8 (28.6%) | ||
| Retired | 26 (43.3%) | 19 (47.5%) | 35 (48.6%) | 10 (35.7%) | ||
| Unemployment or others | 17 (28.3%) | 13 (32.5%) | 20 (27.8%) | 10 (35.7%) | ||
| Monthly income (CNY), n (%) | 0.681 | 0.116 | ||||
| ≤3,000 | 16 (26.7%) | 15 (37.5%) | 25 (34.7%) | 6 (21.4%) | ||
| 3,001–5,000 | 19 (31.7%) | 12 (30%) | 22 (30.6%) | 9 (32.1%) | ||
| 5,001–10,000 | 20 (33.3%) | 10 (25%) | 22 (30.6%) | 8 (28.6%) | ||
| >10,000 | 5 (8.3%) | 3 (7.5%) | 3 (4.2%) | 5 (17.9%) | ||
| Duration of hemodialysis (months), n (%) | 0.550 | 0.276 | ||||
| 3 −36 | 25 (41.7%) | 16 (40.0%) | 19 (26.4%) | 4 (14.3%) | ||
| 37–72 | 20 (33.3%) | 17 (42.5%) | 27 (37.5%) | 15 (53.6%) | ||
| 73–108 | 8 (13.3%) | 2 (5.0%) | 14 (19.4%) | 7 (25.0%) | ||
| 109 months or more | 7 (11.7%) | 5 (12.5%) | 12 (16.7%) | 2 (7.1%) | ||
| Medical insurance, n (%) | 0.406 | 0.319 | ||||
| 6% Self-pay (Employee) | 40 (66.7%) | 22 (55%) | 46 (63.9%) | 16 (57.1%) | ||
| 40% Self-pay (Resident) | 18 (30%) | 15 (37.5%) | 24 (33.3%) | 9 (32.1%) | ||
| 100% Self-pay | 2 (3.3%) | 3 (7.5%) | 2 (2.8%) | 3 (10.7%) | ||
| ESRD etiology, n (%) | 0.418 | 0.222 | ||||
| Primary glomerulonephritis | 28 (46.7%) | 15 (37.5%) | 35 (48.6%) | 8 (28.6%) | ||
| Diabetes | 15 (25.0%) | 13 (32.5%) | 18 (25.0%) | 10 (35.7%) | ||
| Hypertension | 10 (16.7%) | 10 (25.0%) | 12 (16.7%) | 8 (28.6%) | ||
| Others | 7 (11.7%) | 2 (5.0%) | 7 (9.7%) | 2 (7.1%) | ||
SAS, self-rating anxiety scale; CNY, Chinese Yuan; ESRD, end-stage renal disease.